fda warning bpc-157 safety cancer panel backs compounded BPC-157, KPV peptides in win for RFK Jr An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with This Week at FDA: HHS proposes drug acceleration initiatives, FDA warns companies about falsifying test data, and more RAPS Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing PMC FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

SKU: 31839792038 · From iglepidom.org